within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A16A_OtherAlimentaryTractAndMetabolismProducts.A16AB12_ElosulfaseAlfa;

model ElosulfaseAlfa
  extends Pharmacolibrary.Drugs.ATC.A.A16AB12;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A16AB12</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Elosulfase alfa is a recombinant form of human N-acetylgalactosamine 6-sulfatase (GALNS), indicated for the treatment of mucopolysaccharidosis IVA (MPS IVA, also known as Morquio A syndrome). It is an enzyme replacement therapy approved for use in patients with this rare, inherited, lysosomal storage disorder.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in pediatric and adult patients with MPS IVA following intravenous infusion of elosulfase alfa at 2 mg/kg once weekly over approximately 4 hours.</p><h4>References</h4><ol><li><p>Hendriksz, CJ (2016). Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome). <i>Expert review of clinical pharmacology</i> 9(12) 1521–1532. DOI:<a href=\"https://doi.org/10.1080/17512433.2017.1260000\">10.1080/17512433.2017.1260000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/27855521/\">https://pubmed.ncbi.nlm.nih.gov/27855521</a></p></li><li><p>Tomatsu, S, et al., &amp; Sly, WS (2015). Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?. <i>Molecular genetics and metabolism</i> 114(2) 195–202. DOI:<a href=\"https://doi.org/10.1016/j.ymgme.2014.05.013\">10.1016/j.ymgme.2014.05.013</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24953405/\">https://pubmed.ncbi.nlm.nih.gov/24953405</a></p></li><li><p>Tomatsu, S, et al., &amp; Orii, T (2007). Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase. <i>Molecular genetics and metabolism</i> 91(1) 69–78. DOI:<a href=\"https://doi.org/10.1016/j.ymgme.2007.01.004\">10.1016/j.ymgme.2007.01.004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17336563/\">https://pubmed.ncbi.nlm.nih.gov/17336563</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end ElosulfaseAlfa;
